chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; rash is warm to touch; itching; rash the day of the vaccination just above the injection site and slight arm soreness; rash the day of the vaccination just above the injection site and slight arm soreness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE WARMTH (rash is warm to touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE RASH (rash the day of the vaccination just above the injection site and slight arm soreness) and VACCINATION SITE PAIN (rash the day of the vaccination just above the injection site and slight arm soreness) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE RASH (rash the day of the vaccination just above the injection site and slight arm soreness) and VACCINATION SITE PAIN (rash the day of the vaccination just above the injection site and slight arm soreness). On 09-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE WARMTH (rash is warm to touch) and VACCINATION SITE PRURITUS (itching). On 02-Apr-2021, VACCINATION SITE RASH (rash the day of the vaccination just above the injection site and slight arm soreness) and VACCINATION SITE PAIN (rash the day of the vaccination just above the injection site and slight arm soreness) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE WARMTH (rash is warm to touch) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided.  Additional information: She had a rash the day of the vaccination just above the injection site and slight arm soreness which went away after a day. On 09APR2021 she developed a much larger rash in the same area as before which arm soreness. The rash is very itchy and warm to touch. She also has flu-like symptoms
105 degree fever x3 days, very weak, loss appetite, got easily irritated, her cry changed, runny nose, rash on belly or chest, ear infection.
Within a hour heart palpitations have started; pain in kidney area; later evening body ache; muscle ache; fever; headache; extreme drowsiness; noise in ear; pain behind ear; This is a spontaneous report from a contactable consumer (patient). A 40-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration in left arm on 12Aug2021 at 12:00 (At the age of 40-year-old) as single dose for COVID-19 immunization. Medical history of the patient included Graves disease, allergy to latex. Patient received concomitant/other medications [unspecified] in two weeks. Patient did not receive any other vaccine in four weeks. Patient did not have COVID prior vaccination and was not tested for covid post vaccination. Patient previously took Flagyl on an unspecified date and experienced allergy. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration in left arm on 22Jul2021 at 12:00 as single dose for COVID-19 immunization. On 12Aug2021 at 13:15 within an hour patient experienced heart palpitations have started and pain in kidney area, later evening body ache, muscle ache, fever, headache, extreme drowsiness waking up with headache, pain behind ear and noise in ear. Patient did not receive any treatment in response to the evets. Outcome of the events were Recovering.  Information on the Lot/batch number has been requested.
Fever of 99 degrees F began 3/13/2019. Fever increase to 100.5 degrees F on 3/14/2019. Patient developed change in appetite and activity.
Patient stated that a couple days after receiving the H1N1 vaccine a red area appeared at the vaccination site. The area was sore but not warm to the touch per pt. She stated that a blister formed with no drainage. She came to the Health Department on 2/24/10 to report the event. The site at this time appeared to be a perfect round circle that was red and slightly scaley. There was no warmth, edema, or drainage noted. The pt. stated that the area did itch. Instructed that we would report to CDC VAERS and that she should see her PCP.
This spontaneous case, initially received from a pharmacist on 22-Oct-2018, concerns a 51-year-old, adult male patient. The patient's current condition included phobia of needles (reported as medical history). The patient's concomitant medication included GENVOYA. On 22-Oct-2018, the patient was administered a partial dose of AFLURIA QUADRIVALENT (route of administration: intramuscular, anatomical location: deltoid, batch number: YF40908, expiry date: 30-Jun-2019 and dose: partial dose). It was reported that halfway through the administration of vaccine, the patient jumped since he was terrified of needles. Some vaccine went in and  some squirted out and there was still half a dose in the syringe. The bit that came out went on the patient's skin and the pharmacist cleaned it up with a cotton wool. No adverse events were reported after administration of the vaccine. The reporter assessed this case as serious (medically significant).
2 days after injection patient reported round circular rash around injection site, red, slightly warm, more than 1 inch. Pt advised to follow up with doctor.
it look like shingles; small patch of blisters on my lower back / Smal blister on her waistline on her back; Left arm swelled up like a golf ball at the injection site; Muscle might not have been relaxed enough; Arm was bruised and sore; Arm was bruised and sore; This case was reported by a consumer via call center representative and described the occurrence of vesicular rash in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th July 2020, the patient received the 1st dose of Shingrix. On 14th July 2020, immediately after receiving Shingrix, the patient experienced injection site swelling and pain in arm. In July 2020, the patient experienced bruising of arm and product administration error. On 17th July 2020, the patient experienced vesicular rash and blister. On an unknown date, the outcome of the vesicular rash, blister, injection site swelling and product administration error were unknown and the outcome of the bruising of arm and pain in arm were recovered/resolved.   It was unknown if the reporter considered the vesicular rash, blister, injection site swelling, bruising of arm and pain in arm to be related to Shingrix.  Additional details were reported as follows: Patient received Shingrix and her left arm swelled up like a golf ball at the injection site as the pharmacist was injecting the vaccine. The patient developed a small patch of blisters on patient's lower back. From everything patient had read, it looks like shingles. The pharmacist told her that the muscle might not relaxed enough at the time of vaccine administration Her arm was bruised and sore which resolved the following day.  The patient had a small blister on her waistline on her back.  She described it later as a patch of little blisters approximately 12 blisters and there had been no change at all. The reporter consented to follow up.
No additional AE/PQC; Nurse reported AE for improperly stored administered MMRII; This spontaneous report has been received from a nurse and refers to a patient of unknown age and gender.  The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On 01-JUN-2023, the patient was vaccinated with an improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II)  (product storage error) subcutaneous injection (lot number w034592 was determined to be valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II); expiration date was established as 10-MAY-2024), administered for prophylaxis (strength, and anatomical site of administration were not provided). No additional adverse events were provided.
Swelling and soreness under left armpit   Started day after vaccine was given. Still very swollen and sore currently
Ecchymosis and edema presented at vaccination site 4 days after vaccine. Dr consulted with allergist on 3/17/13. Referred to allergist. Mother has not returned calls for follow-up.
Fever, pain at injection site (left arm) Dull headache, Throat raw and swollen, fatigue, erythema, edema, limited ROM. Dx:  Cellulitis Left Upper arm, Prob allergy to Pnuemonia Vaccine.  Tx:  Decadron 8mg IM,  Rocephin 500 IM, Augmentation XR 1000 BIDX10 days,  Mederol Dose pak.
One week after receiving the 2nd Moderna vaccine I had shingles despite having the Shingrix vaccines 2 years prior.
After first shot sick on couch for 3 days, lethargy, fever, aches, pains, headache, same symptoms as when i had covid August 28, 2020. Very much like flu symptoms, Called medical facility left messages, no one ever called me back.  After second shot same symptoms for 1.5 days, less severe.  For months after had left sided facial numbness from cheek up to eye, numbness and twitching.  Also terrible pains in arms like a hot poker down inside middle of arms down into thumbs, both at the same time. Lasted for a good six months, has subsided now. Large golf ball size lump on right clavicle, lymph node enlargement, that lasted for at least a few weeks.
Did not realize it was broken and then the top cracked off and fell off and cut her; The glass was shattered and no vaccine inside of the vial, the box was all soggy; Vial was broken at the bottom; No vaccine inside of the vial, there is no solution left in the vial; Initial information was received on 25-Jun-2020 regarding an unsolicited valid non-serious case received from a nurse (reporting for self).  This case involves female nurse who stated that, while opening the suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] ( lot U6484AC and expiry date 10-Jan-2021) she did not realize it was broken and then the top cracked off and fell off and cut her (product package associated injury), and mentioned that the glass was shattered and no vaccine inside of the vial, the box was all soggy (product packaging issue), vial was broken at the bottom (product physical issue) and no vaccine inside of the vial, there is no solution left in the vial (product quality issue).  Medical history, past medical treatment(s), vaccination(s), family history and concomitant medications were not provided.   It was a case of product packaging issue, product physical issue and product quality issue.  Details of laboratory data were not reported.  Final diagnosis was product package associated injury.  It was not reported if the patient received a corrective treatment.  The outcome was unknown for the event of product package associated injury and was not applicable for product packaging issue, product physical issue and product quality issue.
After receiving PREVNAR 23 injection, I noticed soreness and swelling at injection site. Later in the day I had pain in my arm and it continued to get worse. That night the pain was severe; the next morning, my arm was red and swollen and I could barely move it. The swelling and redness had spread to my wrist and it was warm to touch. Went to E.R. and ultrasound of my left arm revealed a DVT. I was given XARELTO for 3 months and later received VOLTAREN Gel and Lidocaine patches for pain. However, I am still experiencing pain and weakness in my left arm.
Information has been received from a pharmacist concerning a female patient who on approximately 29-SEP-2009 (one year ago) was vaccinated with a dose of GARDASIL (Lot # not provided). It was reported that the patient recently tested positive for high risk HIV. The patient sought unspecified medical attention. At the time of this report, the patient's outcome was unspecified. Additional information has been requested.
Experienced vertigo symptoms less than 24 hours of vaccine. As of March 24, 2021, still experiencing vertigo symptoms. Although tolerable, yet bothersome, I have to move slowly.   Have not seek treatment. I am letting this run its course and see if it'll disappear within the next day or 2. If not, will seek medical help.
sore throat, headache, runny nose, cough, body aches. starting 1/2/2022
Soreness in arm especially when moving; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in arm especially when moving) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS (DAILY VITAMINS) for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm especially when moving). At the time of the report, PAIN IN EXTREMITY (Soreness in arm especially when moving) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.   This case was linked to MOD-2021-103372 (E2B Linked Report).; Sender's Comments:  MOD-2021-103372:same patient, 2nd dose
Left eye start with black floating objects progressed to flashing white lights and grey matter.  Double vision and blurriness in left eye.   Treatment started with 60mg of Prednisone then Humira.  Had side of effects with both drugs.  Had stop treatment.  Currently on Methotrexate and Leucovorin.
Bells Palsy.   11/03/09 Medical records received for DOS 9/29-11/03.  Office visits.  Child developed excessive and increasing  tearing of L eye s/p vaccine. Progressed to Bell's palsy with inability to close eye and facial asymmetry.  Steroid burst tx. Continued to improve over time until complete facial symmetry and movement returned. Last visit noted viral pharyngitis unrelated to Bell's palsy.
Currently pregnant Estimated date of delivery is October 19th, 2021 -Headache, still have now has been two days since injection -Muffled hearing , still have now has been two days since injection -Pain at injection site, lasted about 24 hours -Muscle pain, lasted about 36 hours -Joint pain, lasted about 36 hours -Tired, still have now has been two days since injection -Fever, lasted about 24 hours -Hot flashes with sweating, lasted about 24 hours -Nausea, lasted about 12 hours -Diarrhea, lasted about 12 hours
vaccine has something that improved her condition; Feels more aware overall; Significant cognitive improvement; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPSYCHIATRIC SYMPTOMS (vaccine has something that improved her condition), ANXIETY (Feels more aware overall) and BEHAVIOURAL THERAPY (Significant cognitive improvement) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Dementia.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NEUROPSYCHIATRIC SYMPTOMS (vaccine has something that improved her condition), ANXIETY (Feels more aware overall) and BEHAVIOURAL THERAPY (Significant cognitive improvement). At the time of the report, NEUROPSYCHIATRIC SYMPTOMS (vaccine has something that improved her condition), ANXIETY (Feels more aware overall) and BEHAVIOURAL THERAPY (Significant cognitive improvement) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
mother called 10/18 with status of child having swollen eyes and rash of face: denies soreness of arm. Asked it "shot reaction?" Referred to urgent care for evaluation (has no medical doctor). 10/25/04 follow up call made to mom. She states that client's swelling and rash were both gone the next day. No other complaints noted. Doctor's appointment scheduled for 10/29/2004. 11/2/04: Reviewed by doctor.
Onset of head ache, nausea, bloating and diarrhea 2 days after taking last of four live virus oral typhoid vaccine capsules. Treatment not sought. Improving after 4 days of illness.
Upset stomach; headache; shivering; body aches; Blood pressure also increased; This case was reported by a consumer via call center representative and described the occurrence of upset stomach in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included hypertension.   On 12th December 2019, the patient received the 1st dose of Shingrix (intramuscular). On 13th December 2019, 1 days after receiving Shingrix, the patient experienced upset stomach, headache, shivering, general body pain and increased blood pressure. On an unknown date, the outcome of the upset stomach, headache, shivering, general body pain and increased blood pressure were recovering/resolving.   It was unknown if the reporter considered the upset stomach, headache, shivering, general body pain and increased blood pressure to be related to Shingrix.  Additional details were reported as follows: The patient developed upset stomach, headache, shivering, and body aches. The patient stated that her blood pressure also increased. The patient consented to follow up.      Lab Comments: on an unknown date blood pressure was noted
Narrative: Patient contacted Facility stating he had tested positive for COVID at outside hospital. Covid vaccines reported but not given at Facility.
dizziness; vertigo; nausea; This is a spontaneous report from a contactable consumer (reporting herself). This 51 year old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EM9810), via an unspecified route of administration in left arm on 09Feb2021 at 14:45 as a single dose for COVID-19 immunisation. The patient did not received any other vaccine in 4 weeks of COVID vaccination. The patient did not received any other medication in two weeks of COVID vaccination. On 28Jan2021, the patient underwent Nasal Swab COVID test post vaccination which resulted as negative. On 10Feb2021, the patient did not feel sore arm until around 9pm. Approximately 5 hours later at 05:00, after sleep, upon waking, experienced intense dizziness, vertigo, nausea. Dizziness and nausea was currently present while lying, sitting & standing. The patient did not received any treatment for the events. The patient had no COVID before vaccination. On 28Jan2021, the patient underwent Nasal Swab COVID test post vaccination which resulted as negative. The patient received fist dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in left arm on 20Jan2021 at 13:00 as a single dose for COVID-19 immunization previously. The outcome of dizziness and nausea was not recovered and vertigo was unknown.
First dose I had a sore arm and diarrhea Second does I had, nausea, diarrhea, chills, fever, loss of appetite.
Redness over injection site that spread 10 x 10 cm, erythematous, non-tender are over right anterior thigh.  Watch for fever, discoloration or inability to walk.
A small vesicular rash appeared shortly after both doses, on the anterior left abdomen just below the waistline. Skin scraping was negative for fungus. It did not appear to be bacterial. It spontaneously resolved a few weeks after each dose. Sensorineural hearing loss occurred about two weeks after the second dose of the vaccine. This was confirmed by audiometric testing which showed a significant unilateral hearing loss in the right ear.  A prednisone taper was started followed by two transtympanic injections of dexamethasone over the next six weeks. There was no improvement. A hearing aid is now required.
PATIENT RECIEVED FLU SHOT ON 10/10/17 AND STARTED EXPERIENCING REDNESS, SORNESS AND PAIN TENDER TO TOUCH ON THE LOWER PORTION OF HER UPPER ARM. THE PAIN, SORENESS, AND REDNESS WORSENED AND RADIATED TO LOWER PORTION OF RIGHT ARM WHICH SPANNED FROM RADIUS TO ULNAR BONE. PATIENT REPORTED SX TO PHARMACIST ON DUTY AND WAS ADVISED TO GO TO URGENT CARE. PATIENT WENT TO URGENT CARE AND WAS ADVISED TO GO TO ER.
fullness sensation in head associated with fullness in the ears Day 4; fullness sensation in head associated with fullness in the ears Day 4; dizziness; strange sensation in legs upon walking/ they seemed to be rubber like-very strange; I developed transient nausea, followed by a strange sensation in head, no pain, associated with ringing in the ears and subsequent nausea-no vomiting; I developed transient nausea, followed by a strange sensation in head, no pain, associated with ringing in the ears and subsequent nausea-no vomiting; Injection site pain lasted 3 days-not a big deal.; a strange sensation in head, no pain, associated with ringing in the ears; This is a spontaneous report from a contactable physician, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Mar2021 at 14:15 (at the age of 65-year-old), as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD)- sporadic and allergy to bee sting. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Mar2021 at 16:15, approximately one and half hours after injection, the patient developed transient nausea, followed by a strange sensation in head, no pain, associated with ringing in the ears and subsequent nausea-no vomiting. The patient also experienced injection site pain that lasted 3 days. On 06Mar2021,  the following day, the supra tentorial symptoms were worse with a strange sensation in legs upon walking-that only occurred upon getting out of bed that day and spontaneously resolved after walking briefly, they seemed to be rubber like-very strange, no weakness or pain or numbness. On 09Mar2021, day 4, the patient was bothered by the nausea and dizziness and fullness sensation in head associated with fullness in the ears. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome for injection site pain was recovered on 08Mar2021, after 3 days. The clinical outcome of the event transient nausea, ringing in the ears, strange sensation in head, dizziness and strange sensation in legs upon walking-that only occurred upon getting out of bed that day and spontaneously resolved after walking briefly, they seemed to be rubber like-very strange, dizziness and fullness sensation in head associated with fullness in the ears was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sore, stiff arm 6 hours after injection.  Severe migraine 17 hours after injection lasting over 24 hours and still present.  Severe armpit pain into upper left area above breast. and some swelling of lymph nodes and tissue as well. Extremely sore to the touch. Upper arm pain, shoulder pain and upper left back pain.  Unable to sleep because of the pain.  Miserable body aches, muscle aches and bone pain.